Changchun Changsheng Life Science and Technology Co., Ltd. Report issue

For profit Phase 4
Founded: Changchun China (1992)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01982409
First Marketed Drug
2007
amlodipine (norvasc)
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

HEBEI CHANGSHAN